Electronic cigarette use after smoking cessation and lung cancer risk
Yeon Wook Kim / nature - Nature Medicine, Published online: 08 June 2026; doi:10.1038/s41591-026-04469-5A nationwide retrospective analysis of 4.5 million Korean adults found that electronic cigarette use after smoking cessation was associated with higher lung cancer incidence an…
AI Summary: A new analysis finds people who turn to e‑cigarettes after quitting smoking may not be getting the safety upgrade they were promised. Researchers report that vaping post‑cessation is associated with increased lung disease markers and a raised risk profile for lung cancer, undermining harm‑reduction claims and prompting calls for caution and clearer guidance.
Healthcare costs poised to jump 9% in 2027 as health plans blame AI adoption, drug prices
fiercehealthcare - Health plans are projecting the highest medical cost trend in nearly two decades in 2027 with commercial health costs expected to rise 9%, according to a new analysis from PwC.
AI Summary: Health plans are sounding the alarm that next year's healthcare bills will spike about 9%, blaming rapid AI adoption and rising drug prices for the squeeze. Insurers argue technology-driven utilization and expensive therapies are colliding with fragile margins, pushing premiums and plan costs higher unless payers and providers curb spending or demand price relief.
Ultrasensitive blood test predicts head and neck cancer relapse months earlier
medicalxpress - A new study by investigators from Mass General Brigham Cancer Institute has found that an ultrasensitive blood test called HPV-DeepSeek could help identify which people with HPV-associated head and neck cancer still had cancer cells in their bodies after …
AI Summary: Researchers validated an ultrasensitive HPV whole‑genome sequencing blood assay that detects minimal residual disease after surgery for HPV‑positive head and neck cancer, flagging relapse months before clinical signs. Early detection could enable earlier salvage therapy and closer surveillance, potentially changing follow‑up care and improving outcomes for this patient group.